BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Pulakat L, Sumners C. Angiotensin Type 2 Receptors: Painful, or Not? Front Pharmacol 2020;11:571994. [PMID: 33424587 DOI: 10.3389/fphar.2020.571994] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Ahmad S, Ferrario CM. A Ying-Yang Perspective on the Renin Angiotensin System in Cardiovascular Disease. The Renin Angiotensin System in Cardiovascular Disease 2023. [DOI: 10.1007/978-3-031-14952-8_10] [Reference Citation Analysis]
2 Staurengo-Ferrari L, Deng L, Chiu IM. Interactions between nociceptor sensory neurons and microbial pathogens in pain. Pain 2022;163:S57-68. [PMID: 36252233 DOI: 10.1097/j.pain.0000000000002721] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Steckelings UM, Widdop RE, Sturrock ED, Lubbe L, Hussain T, Kaschina E, Unger T, Hallberg A, Carey RM, Sumners C. The Angiotensin AT2 Receptor: From a Binding Site to a Novel Therapeutic Target. Pharmacol Rev 2022;74:1051-135. [PMID: 36180112 DOI: 10.1124/pharmrev.120.000281] [Reference Citation Analysis]
4 Johnstone EKM, Ayoub MA, Hertzman RJ, See HB, Abhayawardana RS, Seeber RM, Pfleger KDG. Novel Pharmacology Following Heteromerization of the Angiotensin II Type 2 Receptor and the Bradykinin Type 2 Receptor. Front Endocrinol (Lausanne) 2022;13:848816. [PMID: 35721749 DOI: 10.3389/fendo.2022.848816] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Gao W, Shen L, Long DD, Pan TT, Wang D, Chai XQ, Hu SS. Angiotensin II type 2 receptor pharmacological agonist, C21, reduces the inflammation and pain hypersensitivity in mice with joint inflammatory pain. Int Immunopharmacol 2022;110:108921. [PMID: 35724606 DOI: 10.1016/j.intimp.2022.108921] [Reference Citation Analysis]
6 Kaur S, Bali A, Singh N, Jaggi AS. Demystifying the dual role of the angiotensin system in neuropathic pain. Neuropeptides 2022. [DOI: 10.1016/j.npep.2022.102260] [Reference Citation Analysis]
7 Busa P, Kuthati Y, Huang N, Wong C. New Advances on Pathophysiology of Diabetes Neuropathy and Pain Management: Potential Role of Melatonin and DPP-4 Inhibitors. Front Pharmacol 2022;13:864088. [DOI: 10.3389/fphar.2022.864088] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Urmila A, Rashmi P, Nilam G, Subhash B. Recent Advances in the Endogenous Brain Renin-Angiotensin System and Drugs Acting on It. J Renin Angiotensin Aldosterone Syst 2021;2021:9293553. [PMID: 34925551 DOI: 10.1155/2021/9293553] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
9 Jayakar S, Shim J, Jo S, Bean BP, Singeç I, Woolf CJ. Developing nociceptor-selective treatments for acute and chronic pain. Sci Transl Med 2021;13:eabj9837. [PMID: 34757806 DOI: 10.1126/scitranslmed.abj9837] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
10 Guo Y, Huang X, Liao W, Meng L, Xu D, Ye C, Chen L, Hu T. Discovery and Optimization of Highly Potent and Selective AT2R Antagonists to Relieve Peripheral Neuropathic Pain. ACS Omega 2021;6:15412-20. [PMID: 34151119 DOI: 10.1021/acsomega.1c01866] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
11 Deng L, Chiu IM. Microbes and pain. PLoS Pathog 2021;17:e1009398. [PMID: 33793668 DOI: 10.1371/journal.ppat.1009398] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
12 Danigo A, Rovini A, Bessaguet F, Bouchenaki H, Bernard A, Sturtz F, Bourthoumieu S, Desmoulière A, Magy L, Demiot C. The Angiotensin II Type 2 Receptor, a Target for Protection and Regeneration of the Peripheral Nervous System? Pharmaceuticals (Basel) 2021;14:175. [PMID: 33668331 DOI: 10.3390/ph14030175] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 3.5] [Reference Citation Analysis]